Abstract

Annual seasonal influenza epidemics of variable severity caused by influenza A and B virus infections result in substantial disease burden worldwide. Seasonal influenza virus circulation declined markedly in 2020-21 after SARS-CoV-2 emerged but increased in 2021-22. Most people with influenza have abrupt onset of respiratory symptoms and myalgia with or without fever and recover within 1 week, but some can experience severe or fatal complications. Prevention is primarily by annual influenza vaccination, with efforts underway to develop new vaccines with improved effectiveness. Sporadic zoonotic infections with novel influenza A viruses of avian or swine origin continue to pose pandemic threats. In this Seminar, we discuss updates of key influenza issues for clinicians, in particular epidemiology, virology, and pathogenesis, diagnostic testing including multiplex assays that detect influenza viruses and SARS-CoV-2, complications, antiviral treatment, influenza vaccines, infection prevention, and non-pharmaceutical interventions, and highlight gaps in clinical management and priorities for clinical research.

MeSH

Vaccines, Influenza, Human, Viruses, Orthomyxoviridae, Infections

Cited by

• Community-acquired and hospital-acquired bacterial co-infections in patients hospitalized with Covid-19 or influenza: a retrospective cohort study. Infection, 2024
• Structural basis of receptor-binding adaptation of human-infecting H3N8 influenza A virus. J Virol, 2025
• A Phase 3 Safety and Efficacy Study of Baloxavir Marboxil in Children Less Than 1 Year Old With Suspected or Confirmed Influenza. Pediatr Infect Dis J, 2025
• The role of programmed cell death in organ dysfunction induced by opportunistic pathogens. Crit Care, 2025
• Uncovering the Mechanisms of BaBaoWuDanYaoMo Against Influenza A Virus and Virus-Induced Inflammation Based on Network Pharmacology and Pharmacological Evaluation. Infect Drug Resist, 2025
• Advances in Diagnostic Techniques for Influenza Virus Infection: A Comprehensive Review. Trop Med Infect Dis, 2025
• Healthcare Workers' Attitudes toward Influenza Vaccination: A Behaviour and Social Drivers Survey. Vaccines (Basel), 2023
• Impact of the COVID-19 pandemic on parvovirus B19 infection rates in pregnancy: is there a post-pandemic epidemic? BMC Pregnancy Childbirth, 2025
• Editorial: Host-cell pathways modulated by influenza virus infection: new insight into pathogenetic mechanisms and cell-targeted antiviral strategies. Front Cell Infect Microbiol, 2024
• Diagnostic Significance of Influenza Symptoms and Signs, and Their Variation by Type/Subtype, in Outpatients Aged ≥ 15 Years: Novi Sad, Serbia. Viruses, 2025
• Influenza vaccine compatibility among hospitalized patients during and after the COVID-19 pandemic. Front Microbiol, 2024
• Zoonotic Animal Influenza Virus and Potential Mixing Vessel Hosts. Viruses, 2023
• Deep-Learning Model for Influenza Prediction From Multisource Heterogeneous Data in a Megacity: Model Development and Evaluation. J Med Internet Res, 2023
• Synergistic Antiviral Activity of European Black Elderberry Fruit Extract and Quinine Against SARS-CoV-2 and Influenza A Virusa. Nutrients, 2025
• The mortality and years of life lost for community-acquired pneumonia before and during COVID-19 pandemic in China. Lancet Reg Health West Pac, 2023
• A Universal Aptamer for Influenza A Viruses: Selection, Recognition, and Infection Inhibition. ACS Pharmacol Transl Sci, 2024
• ATG9A regulates the dissociation of recycling endosomes from microtubules to form liquid influenza A virus inclusions. PLoS Biol, 2023
• Healthcare-seeking behaviours of patients with acute respiratory infection: a cross-sectional survey in a rural area of southwest China. BMJ Open, 2024
• Influenza B Virus Vaccine Innovation through Computational Design. Pathogens, 2024
• Genetic variants in BAT2 are associated with immune responsiveness to influenza vaccination. Front Genet, 2023